LEV2050

What LEV2050 does

LEV2050 (legal entity INBIOLEV S.L.) is an industrial microbiology company founded in 2010 in Navarra, Spain, that designs and manufactures proprietary bioreactors and produces custom microorganisms for the vitivinicultural, agricultural, and food-processing sectors. Its technology stack centers on patented bioreactor platforms — BR-LEV-LC (multi-purpose), BR-CV (sparkling wine pied de cuvée), BR-CAM (agricultural field use), MULTILEV, and LACTILEV — paired with a proprietary bank of approximately 18,000 microorganisms (yeasts, lactic acid bacteria, fungi) and bespoke growth media and activators. Complementing the hardware are biological products such as ASTRIBAL (patent-pending Lactobacillus brevis lysate), non-Saccharomyces yeast lysates (M2, M8), biofertilizers (PSEUDO-PK, HALO-N), and biostimulants (PHICHIA-BIOSTIM, TRICHO-BIOSTIM). LEV2050 produced approximately 250 custom yeasts in 2024 and reports 37 cumulative R&D projects across its 14-year history.

The company monetizes through three interconnected revenue streams: custom microorganism production as a professional service, proprietary bioreactor manufacturing and installation, and product sales of growth media, lysates, biofertilizers, and biostimulants. Additional revenue comes from co-development R&D agreements with industry partners, universities (UPNA, UNAV), and public institutions (CDTI, Gobierno de Navarra, EU H2020). The go-to-market is a direct enterprise field-sales motion targeting renowned wineries across Spanish Denominations of Origin and international wine markets (USA, Chile, Argentina, Portugal, France, Italy, Germany, Austria), with agricultural sales increasingly channeled through cooperatives and distributors.

LEV2050 is privately held by founders and management, with Stellum Capital and Inveready Asset Management jointly holding a 25% minority stake acquired in March 2024. The company is led by CEO David Garcia Yoldi, operates from facilities in Mutilva and Aizoain (Navarra), and is currently expanding production capacity with public co-financing from the Ministerio de Industria.

Name

LEV2050

Legal name

INBIOLEV S.L.

Website

https://lev2050.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

LEV2050 (INBIOLEV S.L.) is a Spanish industrial microbiology company that designs patented bioreactors and produces custom microorganisms — yeasts, lactic acid bacteria, and fungi — for wineries, agricultural operations, and food processors across Europe and the Americas.

Ownership category

akta.pro rank

Product category

Industrial Microbiology Equipment and Bioprocessing

NAICS

Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253), Food Manufacturing (311)

SIC

Food And Kindred Products (2000), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)

akta.pro secondary industries

Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media) (HLAAAJAA), Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts) (CRADAOAI), Enzymes & Processing Aids (Baking, Brewing, Dairy, Meat) (CRADAOAH), Crop Protection Formulations (EC, SC, WG, WP, SL) (AFABAIAA)

Keywords

• Industrial microbiology
• Custom bioreactor manufacturing
• Wine yeast production
• Agricultural biofertilizers
• Food fermentation solutions

Headquarters

HQ city

Aizoáin

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Custom Microorganism Production: LEV2050 designs, multiplies, and produces custom microorganisms (yeasts, lactic acid bacteria, fungi) tailored to specific client needs in viticulture, agriculture, and food processing. Approximately 250 custom yeasts produced in 2024. Revenue generated through bespoke production agreements with wineries, agricultural operations, and food producers.
2. Bioreactor Manufacturing and Sales: LEV2050 designs and manufactures proprietary bioreactors (BR-LEV-LC, BR-CV, BR-CAM, MULTILEV, LACTILEV) for sale and installation at client facilities (wineries, farms, food production plants). Bioreactors range from laboratory scale to 5,000L industrial scale. Revenue from equipment sales, installation, and related engineering services.
3. R&D Collaboration and Project Funding: Collaborative R&D projects with industry partners, universities, and public institutions (CDTI, Gobierno de Navarra, EU H2020). Projects include BIO-STAB-LEV, STAB-VAC-4COV, ECOLEVAPUR, OPTIWINE, BIOVID, BIOFOOD, CONTI-MAS, LEV-AGING, BIOFITOLEV, KACID, MICROECOLEV, EMBUNATUR, BIOFERTILEV, NITRATOS-FREE, FUNGINSECT. Revenue from public grants and co-development agreements.
4. Nutritional Products and Growth Media: Sale of specialized growth media (PICHIA-LEV, TRICHO-LEV, PSEUDO-LEV, BACILLUS-LEV, METHY-LEV, THURI-LEV) and microbial activators for use with LEV2050 bioreactors in agricultural applications.
5. Enological Products (Lysates, Yeast Products): Sale of enological products including M2 and M8 yeast lysates, ASTRIBAL (lactic acid bacteria lysate), and other nutritional products for winemaking (LIA-LEV, TIRA-LEV, LACTILEV, MULTILEV, K-ACID, FLO-1, ASTRIBAL, M-8, M-2, DETOXI-LEV, NUTRI-LEV, INI-LEV-PURE, INI-LEV, PILLOW, POLLOW NON-ETHYL).
6. Custom Process Development and Scaling Services: Process development and scaling services for clients, from laboratory phase through pilot and industrial production. LEV2050 acts as a scaling partner for clients across viticulture, bakery, dairy, meat, brewing, and other sectors. Services cover Lab phase, Scale-up, Pilot, and Industrial production phases.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

LEV2050 designs and manufactures patented bioreactors (BR-LEV-LC, BR-CV, BR-CAM, MULTILEV, LACTILEV) for the controlled on-site multiplication of yeasts, lactic acid bacteria, and fungi, and produces custom microorganisms tailored to client specifications from a bank of approximately 18,000 strains. The company also sells growth media, yeast and bacteria lysates (ASTRIBAL, M2, M8), biofertilizers, biostimulants, and provides lab-to-industrial scaling and process development services for the vitivinicultural, agricultural, and food processing sectors.

Product overview

LEV2050 (INBIOLEV S.L.) is an industrial microbiology company offering a unified portfolio centered on patented bioreactors and custom microorganism solutions. The core offering consists of three bioreactor lines: the BR-LEV-LC (multi-purpose for viticulture and agriculture), BR-CV (specialized for sparkling wine pied de cuvée), and BR-CAM (for agricultural field use). Complementing the bioreactors are growth media products (LIA-LEV, TIRA-LEV, LACTILEV, MULTILEV, K-ACID, and agricultural-specific media PICHIA-LEV, TRICHO-LEV, PSEUDO-LEV, BACILLUS-LEV, METHY-LEV, THURI-LEV), yeast lysate refiners (M2, M8, ASTRIBAL), and six microbiological activators for field application. The company maintains a microorganism bank of approximately 18,000 strains and provides custom production services for microorganisms. The portfolio serves three sectors: viticulture (with solutions for yeast multiplication, malolactic fermentation, sparkling wine production, and wine refinement), agriculture (with biofertilizers PSEUDO-PK and HALO-N, biostimulants PHICHIA-BIOSTIM and TRICHO-BIOSTIM), and food processing (including probiotics, postbiotics, and fermentation solutions for bakery, meat, dairy, and brewing sectors).

Differentiator

Problem solved

Functional benefit

Products and services

• BR-LEV-LC Bioreactor Patented versatile bioreactor for multiplication of yeasts, lactic acid bacteria, and fungi, enabling controlled on-site biomass production for viticulture and agriculture applications. Capacities from 75L to 5,000L with software-controlled automation of temperature, agitation, and oxygen.
• BR-CV Bioreactor Patented automated bioreactor specialized for sparkling wine pied de cuvée generation, featuring controlled ethanol adaptation for yeast with exclusive automation of temperature, oxygen, nutrient addition, wine, and sugar control. Cell concentration exceeds 200 million cells/mL with >90% viability after 5 days.
• BR-CAM Bioreactor Bioreactor developed for agricultural field application, designed for simple, safe, and efficient use in any agricultural setting, enabling induction and activation of microorganisms directly in the field through the BIMA system.
• MULTILEV and MULTILEV TIRAGE Bioreactors Patented multi-purpose bioreactor for viticulture applications providing versatility across different microbiological processes, with a specialized TIRAGE variant for sparkling wine tirage processes.
• LACTILEV Bioreactor Patented bioreactor series designed for multiplication of lactic bacteria in viticulture applications, enabling on-site controlled production of malolactic fermentation cultures.
• Pasteurizable and Autoclavable Bioreactors with CIP Cleaning Units Bioreactors that can be pasteurized in situ and autoclaved, along with CIP cleaning units, covering all processes involving microbiology in the food sector.
• Custom Microorganism Production Service Bespoke production service for selected microorganisms including yeasts, lactic acid bacteria, and fungi. Approximately 250 custom yeasts were produced in 2024, with bioreactors of various capacities for small or large-scale production tailored to specific client operational needs.
• Microorganism Selection Studies Custom research projects from lab phase through scaling and production, including isolation and selection of indigenous microorganisms from spontaneous fermentations for vitivinicultural applications.
• Probiotic and Postbiotic Production Service Custom development of probiotic cultures with specific functional properties, production of microbial biomass with high viability, and postbiotics (lysates) with technological and health applications for the food processing sector.
• ASTRIBAL Patented lysate from Lactobacillus brevis lactic acid bacteria with low Z potential, improving colloidal stability, correcting aggressive tannins, and increasing aromatic complexity in wines.
• M2 Yeast Lysate Polysaccharide-rich yeast lysate from non-Saccharomyces yeasts, providing sweetness, volume, and reduction of astringency and bitterness in white, rosé, and sparkling wines.
• M8 Yeast Lysate Protein-rich yeast lysate from non-Saccharomyces yeasts, designed for red wines to improve structure, reduce aggression, bitterness, and astringency.
• PSEUDO-PK Biofertilizer Biofertilizer that improves solubilization of phosphorus and potassium for agricultural crops, reducing dependence on chemical fertilizers.
• HALO-N Biofertilizer Biofertilizer that favors nitrogen availability and assimilation in crops, reducing chemical nitrogen fertilizer inputs.
• PHICHIA-BIOSTIM Biostimulant Biostimulant that stimulates plant growth and contributes to control of pathogenic fungi in agricultural applications.
• TRICHO-BIOSTIM Biostimulant Biostimulant that favors root development and acts against soil pathogens, improving soil health and crop resilience.
• Viticulture Growth Media (LIA-LEV, TIRA-LEV, LACTILEV-PLANTARUM, LACTILEV-OENI, K-ACID, FLO-1, DETOXI-LEV, NUTRI-LEV, INI-LEV-PURE, INI-LEV, PILLOW, POLLOW NON-ETHYL) Specialized growth media and nutritional products for use with LEV2050 bioreactors in viticulture applications, supporting yeast multiplication, lactic bacteria cultivation, sparkling wine tirage, detoxification, and specific strain applications.
• Agricultural Growth Media and Microbial Activators (PICHIA-LEV, TRICHO-LEV, PSEUDO-LEV, BACILLUS-LEV, METHY-LEV, THURI-LEV and matching ACTIVADOR products) Specialized growth media and microbial activators for bioreactor induction of Pichia, Trichoderma, Pseudomonas, Bacillus, Methylobacterium, and Bacillus thuringiensis strains for biostimulant, biocontrol, and crop protection applications in agriculture.

Quantifiable outcome

• Up to 90% cost savings on microorganisms for wineries using LEV2050 bioreactors
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

21 partnerships are on record, tiered core and minor.

• CERTESTcoreStrategic or Co-development PartnerCollaboration on the STAB-VAC-4COV project for researching new RNA-based vaccines, including those targeting SARS-CoV-2 Delta variant with stabilized S protein. LEV2050's role is obtaining expression pathways for synthesizing enzymes from non-conventional yeasts.
• LEVPROT BiosciencecoreStrategic or Co-development PartnerPart of the STAB-VAC-4COV consortium developing RNA-based vaccines. LEV2050 collaborates with LEVPROT Bioscience on enzyme synthesis pathways from non-conventional yeasts.
• BDI BiotechminorStrategic or Co-development PartnerPart of the STAB-VAC-4COV vaccine development consortium alongside CERTEST, LEVPROT Bioscience, and INNOUP.
• INNOUPminorStrategic or Co-development PartnerPart of the STAB-VAC-4COV vaccine development consortium, contributing to the overall project objectives.
• TIMAC-AGROcoreStrategic or Co-development PartnerCollaboration on the ECOLEVAPUR project developing new technology for valorizing pig farming waste through aerobic biotransformation to produce high-value fertilizers for sustainable agriculture.
• BLUE AGRO BIOSCIENCEcoreStrategic or Co-development PartnerConsortium partner in the BIOVID project (testing yeast-based Botrytis control in vineyards) and the BIOFITOLEV project (developing yeast-based antifungal products for soil and post-harvest applications) in collaboration with the Instituto de Agriobiotecnología (UPNA-CSIC-Gobierno de Navarra).
• INBIOLEVcoreStrategic or Co-development PartnerINBIOLEV is the legal entity name of LEV2050. Listed as a consortium partner in the BIOVID project for sustainable viticulture and Botrytis control in vineyards.
• LUREDERRAminorStrategic or Co-development PartnerTechnology center participating in the BIOVID project consortium for testing yeast-based biocontrol solutions in vineyards.
• UPNA (Universidad Pública de Navarra)coreStrategic or Co-development PartnerUniversity partner in multiple R&D projects including BIOVID, BIOFERTILEV (with Alfa y Omega), and BIOFITOLEV (with Instituto de Agriobiotecnología). Contributes research expertise in viticulture, microbiology, and agricultural biotechnology.
• OTAZUminorStrategic or Co-development PartnerWinery participating in the BIOVID project consortium, testing yeast-based Botrytis control in vineyards across different agro-climatic zones of Navarra.
• INURRIETAminorStrategic or Co-development PartnerWinery participating in the BIOVID project consortium for testing sustainable yeast-based vineyard disease control solutions.
• PRÍNCIPE DE VIANAminorStrategic or Co-development PartnerWinery participating in the BIOVID project consortium for testing sustainable viticulture solutions in Navarra vineyards.
• BiosasunminorStrategic or Co-development PartnerParticipant in the BIOFOOD project (SIBERIA challenge) focused on studying bioprocesses that generate health benefits and help prevent disease development, investigating gut microbiota and fermented food production.
• BrotaliaminorStrategic or Co-development PartnerParticipant in the BIOFOOD project consortium studying bioprocesses and health benefits of fermented foods and gut microbiota interactions.
• GarunkookminorStrategic or Co-development PartnerParticipant in the BIOFOOD project consortium focused on bioprocesses and health benefits related to food fermentation.
• NucapsminorStrategic or Co-development PartnerConsortium partner in the BIOFOOD project investigating bioprocesses for health benefits from fermented foods and gut microbiota.
• UNAV (Universidad de Navarra)minorStrategic or Co-development PartnerUniversity partner in the BIOFOOD project studying health benefits of bioprocesses and fermented foods.
• CNTA (Centro Nacional de Tecnología y Seguridad Alimentaria)minorStrategic or Co-development PartnerTechnology center partner in the BIOFOOD project for studying bioprocesses, fermented foods, and gut health.
• Alfa y OmegaminorStrategic or Co-development PartnerPartner with LEV2050 and UPNA in the Biofertilev project (GN I+D 2017) developing a new organic biofertilizer based on synergy between yeasts, elicitor extracts, and active stimulants for plant growth promotion.
• INCANASAminorStrategic or Co-development PartnerCollaboration on the EMBUNATUR project developing new meat formulations for cured sausages with improved organoleptic characteristics and reduced fat content through fermentation processes.
• Instituto de Agriobiotecnología (UPNA-CSIC-Gobierno de Navarra)coreStrategic or Co-development PartnerResearch institute partner in the BIOFITOLEV project with LEV2050 and BLUE AGRO BIOSCIENCE, developing zero-residue antifungal products for soil and post-harvest applications based on yeast biochemical mechanisms.

Scale indicators7 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Lallemand: Lallemand is a global leader in yeast and bacteria production for the wine, baking, brewing, and bio-ingredients industries, with a vast strain library and a worldwide distribution network. It is comparable to LEV2050 as a much larger incumbent offering custom and standard microorganisms across overlapping end markets, particularly wine.
• Lesaffre: Lesaffre is one of the world's largest yeast producers, serving baking, wine, brewing, human nutrition, and biotechnology applications, with a strong custom-yeast and fermentation services portfolio. It overlaps with LEV2050 in wine and food fermentation, but at significantly greater scale and geographic reach.
• Novonesis (formerly Chr. Hansen): Novonesis (the merged Chr. Hansen / Novozymes biosolutions business) provides microbial and enzyme solutions for food, agriculture, and human health, including starter cultures and biocontrol products. It overlaps with LEV2050 across food fermentation starters and agricultural biologicals, but operates at far larger scale with broader product portfolios.
• DSM-Firmenich: DSM-Firmenich is a global ingredient and bioscience company with food, beverage, and agricultural biological offerings, including yeast extracts, fermentation-derived ingredients, and animal nutrition solutions. It is comparable to LEV2050 as a broad incumbent serving similar end markets with microbial and fermentation-derived products.
• Kerry Group: Kerry Group is a global taste and nutrition company with fermentation-derived ingredients and food biotechnology capabilities, including cultures, enzymes, and flavor systems. It is comparable to LEV2050 as a broad incumbent offering fermentation-derived ingredients to the food and beverage industry.
• Koppert Biological Systems: Koppert is a global leader in biological crop protection and pollination, supplying biocontrol agents, biostimulants, and pollination products for horticulture and agriculture. It overlaps with LEV2050's biofertilizer, biostimulant, and biocontrol product lines (PSEUDO-PK, HALO-N, PHICHIA-BIOSTIM, TRICHO-BIOSTIM) but serves primarily horticulture and arable crops.

Direct peers

• AB Mauri: AB Mauri is a global bakery ingredients company supplying yeast, bakery ingredients, and fermentation solutions to industrial and craft bakeries. It is comparable to LEV2050 in supplying custom yeast and fermentation solutions to the bakery and food-processing sector, though with a primary focus on baking rather than wine.

Emerging players

• AB Biotics: AB Biotics is a Spanish biotech company developing probiotic and microbiome-based solutions for human and animal health, with a strain library and proprietary production capability. It is comparable to LEV2050 as a smaller Spanish/European biotech leveraging proprietary microorganisms for differentiated solutions, though focused on health rather than food/agriculture.
• Biosearch Life: Biosearch Life (a subsidiary of Evonik) develops and produces probiotic strains and postbiotic ingredients for food, nutraceutical, and infant nutrition markets. It is comparable to LEV2050 in producing custom microbial biomass and probiotic/postbiotic ingredients, with a strong fermentation and strain-development capability overlapping with LEV2050's food-processing offerings.

Regional players

• Bioiberica: Bioiberica is a Spanish biotech company specializing in animal health, plant health, and bioactive ingredients derived from biological sources, including biostimulants and biocontrol solutions. It is comparable to LEV2050 as a regional biotech peer in agricultural biologicals with overlapping biostimulant and biocontrol product lines, though at larger scale and broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@InBioLev
• LinkedInlinkedin.com/company/lev2050
• Facebookfacebook.com/lev.inbiolev

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LEV2050